Moreover, FLT3, encoding a class III receptor tyrosine kinase, exhibited reduced expression in a significant proportion of HCC patients, which was consistent with our findings that FLT3 was decreased in HCC tumor tissues [23]. The gene discussed is FLT3; the disease is hepatocellular carcinoma.